About TRiCares
TRiCares is a company based in Aschheim (Germany) founded in 2013. TRiCares has raised $102.84 million across 5 funding rounds from investors including GO CAPITAL, Andera Partners and European Union. TRiCares offers products and services including Topaz Heart Valve Prosthesis and Topaz Implantation System. TRiCares operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Aschheim, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tricares Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$102.84 M (USD)
in 5 rounds
-
Latest Funding Round
$23.26 M (USD), Debt – Conventional
Jan 20, 2026
-
Investors
GO CAPITAL
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TRiCares
TRiCares offers a comprehensive portfolio of products and services, including Topaz Heart Valve Prosthesis and Topaz Implantation System.
Minimally invasive system for replacing tricuspid valves in heart patients.
Tool for catheter-based heart valve implantation procedures.
Funding Insights of TRiCares
TRiCares has successfully raised a total of $102.84M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $23.26 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TRiCares
TRiCares has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include GO CAPITAL, Andera Partners and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in medical technology innovations.
|
Locked | Locked | Locked | |
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked | |
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Locked | Locked | Locked |
Investor details for TRiCares
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TRiCares
Investment portfolio details for TRiCares
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TRiCares
Detailed financials for TRiCares
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tricares Comparisons
Peer comparison for TRiCares
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TRiCares
TRiCares operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| Locked | Locked | Locked |
Smart medical devices for heart valve diseases are developed.
|
Detailed competitors of TRiCares
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tricares
Complete news archive for TRiCares
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TRiCares
TRiCares was founded in 2013 and raised its 1st funding round 5 years after it was founded.
TRiCares is headquartered in Aschheim, Germany. It is registered at Aschheim, Bavaria, Germany.
Ahmed Elmouelhi is the current CEO of TRiCares.
TRiCares is a funded company, having raised a total of $102.84M across 5 funding rounds to date.
The company was founded in 2013 in Aschheim, Germany, and operates within the medical device sector focused on cardiology. A catheter-based system for tricuspid valve replacement is being developed to treat tricuspid regurgitation without open-heart surgery. Clinical trials are conducted to evaluate efficacy and safety, while funding is secured to support ongoing research and development milestones. Leadership is provided by CEO Ahmed Elmouelhi.
TRiCares's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
TRiCares offers Topaz Heart Valve Prosthesis and Topaz Implantation System.
TRiCares has 11 investors. Key investors include GO CAPITAL, Andera Partners, European Union, 415 Capital, and BioMedPartners.